BDX — Becton Dickinson and Company stock price and chart

BDX

Becton Dickinson and CompanyStock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.06% · Russell 1000 0.06% · Russell 3000 0.06% · US Stock Market 0.06% · MSCI World 0.05% · MSCI ACWI 0.04%

$177.85+0.81%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

120.0130.0140.0150.0160.0170.0180.0190.0200.0210.0220.0020.0M$177.85

2026-09-11

Price$177.85

MA20$159.60

MA50$155.60

Vol9.3M

What would $1,000 invested in BDX be worth today? →

BDX returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $177.85
Change YTD: +18.84%
Next earnings: Nov 5, 2026
Market cap: 48.4B2016-09 29.3B2026-09 48.4B+65.5% over the window
Enterprise value: 65.4B
Shares outstanding: 272.4M2016-06 212.9M2026-06 272.4M+27.9% over the window
52W low: $127.59
52W high: $193.07
From 52W high: -7.88%
From 52W low: +39.40%
52W range: 77%
Beta: 0.20

Volume

Rel volume: 0.89×
30D volume: 1.8M
30D $ vol: 319.4M

Fundamentals

Sales (ttm): 23.3B2016-06 12.3B2026-06 23.3B+88.9% over the window
Sales/share: $85.362016-06 $57.812026-06 $85.36+47.6% over the window
EPS (ttm): $3.332016-06 $5.262026-06 $3.33-36.7% over the window
FCF (ttm): 3.2B2016-06 1.9B2026-06 3.2B+67.0% over the window
FCF/share: $11.762016-06 $9.012026-06 $11.76+30.5% over the window
Book value/share: $89.642016-06 $37.732026-06 $89.64+137.6% over the window
Net margin: 4.05%2016-06 9.2%2026-06 4.0%-56.2% over the window
ROE: 3.85%2016-06 14.2%2026-06 3.9%-72.8% over the window
ROA: 1.85%2016-06 4.4%2026-06 1.9%-57.6% over the window
Debt / equity: 0.55×2016-06 1.312026-06 0.55-57.9% over the window
Current ratio: 0.872016-06 1.552026-06 0.87-44.1% over the window

Growth (CAGR, ttm) · 10Y

Sales: +17.37%2025-06-30 → 2026-06-3019.8B → 23.3B (+17.4% total)+6.87%2023-06-30 → 2026-06-3019B → 23.3B (+22.1% total)+3.46%2021-06-30 → 2026-06-3019.6B → 23.3B (+18.5% total)+6.57%2016-06-30 → 2026-06-3012.3B → 23.3B (+88.9% total)
Net income: -40.65%2025-06-30 → 2026-06-301.6B → 941M (-40.6% total)-17.30%2023-06-30 → 2026-06-301.7B → 941M (-43.4% total)-13.61%2021-06-30 → 2026-06-302B → 941M (-51.9% total)-1.88%2016-06-30 → 2026-06-301.1B → 941M (-17.3% total)
FCF: +54.26%2025-06-30 → 2026-06-302.1B → 3.2B (+54.2% total)+22.48%2023-06-30 → 2026-06-301.7B → 3.2B (+83.8% total)-5.56%2021-06-30 → 2026-06-304.3B → 3.2B (-24.9% total)+5.26%2016-06-30 → 2026-06-301.9B → 3.2B (+67.0% total)
Shares: -4.97%2025-06-30 → 2026-06-30286.6M → 272.4M (-5.0% total)-2.08%2023-06-30 → 2026-06-30290.1M → 272.4M (-6.1% total)-1.05%2021-06-30 → 2026-06-30287.2M → 272.4M (-5.2% total)+2.49%2016-06-30 → 2026-06-30212.9M → 272.4M (+27.9% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: -39.22%2025-06-30 → 2026-06-30$5.48 → $3.33 (-39.2% total)-16.90%2023-06-30 → 2026-06-30$5.81 → $3.33 (-42.6% total)-12.16%2021-06-30 → 2026-06-30$6.37 → $3.33 (-47.7% total)-4.46%2016-06-30 → 2026-06-30$5.26 → $3.33 (-36.7% total)
Sales/share: +23.51%2025-06-30 → 2026-06-30$69.12 → $85.36 (+23.5% total)+9.14%2023-06-30 → 2026-06-30$65.65 → $85.36 (+30.0% total)+4.56%2021-06-30 → 2026-06-30$68.29 → $85.36 (+25.0% total)+3.97%2016-06-30 → 2026-06-30$57.81 → $85.36 (+47.6% total)
FCF/share: +62.33%2025-06-30 → 2026-06-30$7.25 → $11.76 (+62.3% total)+25.08%2023-06-30 → 2026-06-30$6.01 → $11.76 (+95.7% total)-4.55%2021-06-30 → 2026-06-30$14.84 → $11.76 (-20.8% total)+2.70%2016-06-30 → 2026-06-30$9.01 → $11.76 (+30.5% total)
Book value/share: +0.87%2025-06-30 → 2026-06-30$88.87 → $89.64 (+0.9% total)+0.09%2023-06-30 → 2026-06-30$89.40 → $89.64 (+0.3% total)+1.30%2021-06-30 → 2026-06-30$84.04 → $89.64 (+6.7% total)+9.04%2016-06-30 → 2026-06-30$37.73 → $89.64 (+137.6% total)
Dividend/share: +9.48%2024-09-30 → 2025-09-30$3.80 → $4.16 (+9.5% total)+6.13%2022-09-30 → 2025-09-30$3.48 → $4.16 (+19.5% total)+5.65%2020-09-30 → 2025-09-30$3.16 → $4.16 (+31.6% total)+5.65%2015-09-30 → 2025-09-30$2.40 → $4.16 (+73.3% total)
Price: +18.73%2025-09-11 → 2026-09-11$149.81 → $177.85 (+18.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-5.39%2023-09-11 → 2026-09-11$210.05 → $177.85 (-15.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-2.14%2021-09-10 → 2026-09-11$198.14 → $177.85 (-10.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+3.09%2016-09-09 → 2026-09-11$131.16 → $177.85 (+35.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +21.88%2025-09-11 → 2026-09-11$145.94 → $177.85 (+21.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-3.06%2023-09-11 → 2026-09-11$195.24 → $177.85 (-8.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+0.02%2021-09-10 → 2026-09-11$177.68 → $177.85 (+0.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+5.13%2016-09-09 → 2026-09-11$107.87 → $177.85 (+64.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 53.4×2016-09 29.992026-09 51.48+71.7% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 19.5×2016-09 20.472026-09 19.52-4.6% over the window
Fwd P/E: 13.5×
P/S (ttm)Market cap ÷ TTM revenue.: 2.1×2016-09 2.342026-09 2.08-11.1% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.0×2016-09 3.832026-09 1.98-48.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 15.1×2016-09 15.692026-09 15.12-3.6% over the window
EV/EBITDA (fy): 13.1×
EV/Sales (ttm): 2.8×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.61%2016-06 6.6%2026-06 7.7%+18.1% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 2.34%
Dividend/share (fwd): $4.16
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 272.4M ÷ 286.6M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 4.97%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (4.97%) + dividends paid over that year ($1.2B) ÷ market_cap_at(2025-06-30) ($38.8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 8.05%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($2.5B) ÷ today's market cap ($48.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 5.16%2016-06 0.0%2026-06 6.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $2.5B + TTM dividends $1.2B) ÷ today's market cap ($48.4B). Same caveat as the cash buyback yield.: 7.63%2016-06 1.9%2026-06 6.0%+222.7% over the window

Vs own 10Y history

P/E: 79th
P/OI: 19th
P/S: 11th
P/B: 17th
P/FCF: 12th

Bar = where today’s multiple sits in BDX’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

+0.81%

-4.65%

-2.55%

+21.41%

YTD

+18.84%

+23.24%

+1.77%

Financial statements

Open full BDX financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

Becton Dickinson and Company (BDX) trades at $177.85 with a live price and an interactive chart covering 53+ years of daily price history, plus key valuation metrics. ChartRow also publishes BDX’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full BDX financial statements →

BDX — Becton Dickinson and Company price, chart and key statistics